CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist

33.45
-0.21-0.62%

Market Closed Nov 13 15:00 CST

26.71BMarket Cap33.22P/E (TTM)

Jafron Biomedical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Operating Cash Flow

Goods sale service render cash

30.04%2.31B

36.11%1.66B

44.68%878.54M

-18.60%2.37B

-17.77%1.78B

-17.25%1.22B

-10.14%607.21M

0.30%2.91B

17.24%2.16B

19.72%1.47B

Refunds of taxes and levies

-40.22%1.43M

-45.29%1.19M

-69.21%428.15K

-79.19%2.4M

-77.97%2.39M

-77.44%2.17M

453.98%1.39M

2,304.71%11.55M

3,001.52%10.84M

20,711.73%9.63M

Cash received relating to other operating activities

-48.85%56.84M

-32.02%45.57M

2.89%23.7M

4.72%153.4M

52.88%111.13M

4.99%67.03M

172.02%23.04M

-14.55%146.49M

-30.76%72.69M

-23.55%63.85M

Cash inflows from operating activities

25.31%2.37B

32.42%1.7B

42.91%902.68M

-17.71%2.52B

-15.77%1.89B

-16.71%1.29B

-7.72%631.64M

-0.17%3.07B

15.18%2.24B

17.70%1.54B

Goods services cash paid

-8.80%281.61M

-3.39%162.6M

-10.15%71.27M

-43.56%318.42M

-35.43%308.78M

-41.90%168.31M

-51.30%79.32M

20.12%564.2M

60.31%478.19M

51.46%289.71M

Staff behalf paid

3.29%451.8M

-1.52%308.86M

-11.92%114.03M

-17.11%570.81M

-10.60%437.41M

-5.53%313.61M

4.94%129.46M

40.39%688.62M

41.88%489.25M

43.67%331.99M

All taxes paid

91.94%357.96M

88.21%228.48M

11.09%88.15M

-43.12%257.94M

-53.34%186.49M

-49.65%121.4M

-47.60%79.35M

5.93%453.49M

25.59%399.71M

21.34%241.1M

Cash paid relating to other operating activities

10.33%403.58M

3.12%253.51M

17.15%122.13M

-3.55%459.58M

4.55%365.81M

5.79%245.84M

-12.20%104.25M

9.81%476.51M

9.67%349.9M

17.16%232.38M

Cash outflows from operating activities

15.13%1.49B

12.28%953.46M

0.82%395.58M

-26.39%1.61B

-24.38%1.3B

-22.46%849.17M

-29.48%392.38M

19.79%2.18B

34.10%1.72B

33.65%1.1B

Net cash flows from operating activities

47.72%871.6M

71.58%749.27M

111.94%507.1M

3.73%916.74M

12.37%590.04M

-2.67%436.7M

86.83%239.26M

-29.26%883.8M

-21.17%525.09M

-8.87%448.67M

Investing cash flow

Cash received from disposal of investments

--1.55B

--1.03B

--422M

----

--0

----

-49.84%2.2B

-9.01%2.1B

12.67%1.8B

Cash received from returns on investments

--24.46M

--8.18M

--2.53M

----

--0

----

-63.34%10.52M

-41.49%10.48M

-22.32%9.66M

Net cash received from disposal of fix assets、 intangible assets 、other long-term asset

-59.33%4.89M

-99.25%69.83K

-99.14%69.03K

82.51%12.6M

6,418.83%12.02M

4,930.87%9.28M

4,384.80%8.02M

599.46%6.91M

-83.80%184.4K

-78.32%184.4K

Cash inflows from investing activities

12,997.70%1.57B

11,091.74%1.04B

5,192.05%424.6M

-99.43%12.6M

-99.43%12.02M

-99.49%9.28M

-99.56%8.02M

-49.78%2.22B

-9.30%2.11B

12.35%1.81B

Cash paid to acquire fixed assets intangible assets and other long-term assets

77.76%179.48M

76.59%128.1M

170.66%95.87M

-48.04%247.25M

-75.84%100.96M

-74.62%72.54M

-75.77%35.42M

-11.45%475.89M

-4.08%417.89M

-0.59%285.87M

Cash paid to acquire investments

--3.57B

--2.03B

--1.17B

-99.27%15M

--0

----

-54.98%2.05B

-39.51%1.95B

2.33%1.65B

Cash paid relating to other investing activities

----

--184.02K

----

Cash outflows from investing activities

3,616.42%3.75B

2,868.76%2.15B

3,468.27%1.26B

-89.62%262.25M

-95.74%100.96M

-96.25%72.54M

-98.03%35.42M

-50.38%2.53B

-35.29%2.37B

1.89%1.94B

Net cash flows from investing activities

-2,348.52%-2.18B

-1,662.98%-1.12B

-2,963.44%-839.27M

18.39%-249.65M

65.05%-88.94M

48.69%-63.27M

-257.25%-27.4M

54.36%-305.9M

80.85%-254.49M

57.01%-123.29M

Financing cash flow

Cash received from capital contributions

--0

----

-99.81%128.11K

--128.11K

-65.51%67.29M

----

Cash from borrowing

-60.04%294.43M

-41.27%262.16M

-23.37%251.83M

157.47%762.92M

332.91%736.78M

--446.37M

--328.63M

--296.32M

--170.19M

----

Cash received relating to other financing activities

-60.79%50M

-61.44%50M

----

1,063.62%130.17M

1,262.90%127.51M

1,875.51%129.66M

-87.37%437.77K

25.08%11.19M

3,253.97%9.36M

-32.78%6.56M

Cash inflows from financing activities

-60.15%344.43M

-45.82%312.16M

-23.50%251.83M

138.32%893.21M

381.44%864.41M

8,678.58%576.16M

9,396.94%329.2M

-68.83%374.79M

-84.95%179.55M

-99.45%6.56M

Borrowing repayment

39.21%364.16M

12,637.81%254.76M

--126.5M

--344.5M

--261.59M

--2M

----

Dividend interest payment

-40.02%334.67M

-40.03%330.44M

7.86%5.53M

-22.98%561.79M

-22.51%557.94M

-23.47%550.99M

--5.13M

37.36%729.42M

35.59%720M

35.59%719.99M

Cash payments relating to other financing activities

-2.76%373.29M

44.74%373.29M

--213M

3,783.19%438.84M

7,293.43%383.87M

--257.91M

----

-97.77%11.3M

-98.21%5.19M

----

Cash outflows from financing activities

-10.91%1.07B

18.20%958.49M

6,628.19%345.04M

81.60%1.35B

65.94%1.2B

12.63%810.89M

--5.13M

-28.58%740.72M

-11.73%725.19M

35.59%719.99M

Net cash flows from financing activities

-114.67%-727.69M

-175.35%-646.33M

-128.76%-93.21M

-23.50%-451.91M

37.87%-338.98M

67.10%-234.73M

9,249.00%324.07M

-321.54%-365.93M

-247.04%-545.64M

-208.59%-713.42M

Net cash flow

Exchange rate change effecting cash and cash equivalents

-4,146.55%-787.74K

428.53%95.71K

78.47%-48.88K

131.31%11.39K

-101.49%-18.55K

-104.43%-29.13K

-751.92%-226.98K

-756,607.69%-36.4K

1,771.24%1.24M

6,877.56%657.23K

Net increase in cash and cash equivalents

-1,355.16%-2.03B

-830.02%-1.01B

-179.41%-425.43M

1.54%215.19M

159.20%162.1M

135.80%138.67M

259.56%535.71M

-71.53%211.93M

6.18%-273.8M

-144.91%-387.39M

Add:Begin period cash and cash equivalents

8.52%2.74B

9.16%2.53B

47.41%2.31B

End period cash equivalent

-73.71%706.92M

-35.11%1.73B

-24.36%2.32B

8.52%2.74B

31.75%2.69B

38.30%2.67B

24.30%3.06B

9.16%2.53B

59.64%2.04B

-20.78%1.93B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Thornton Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash	30.04%2.31B	36.11%1.66B	44.68%878.54M	-18.60%2.37B	-17.77%1.78B	-17.25%1.22B	-10.14%607.21M	0.30%2.91B	17.24%2.16B	19.72%1.47B
Refunds of taxes and levies	-40.22%1.43M	-45.29%1.19M	-69.21%428.15K	-79.19%2.4M	-77.97%2.39M	-77.44%2.17M	453.98%1.39M	2,304.71%11.55M	3,001.52%10.84M	20,711.73%9.63M
Cash received relating to other operating activities	-48.85%56.84M	-32.02%45.57M	2.89%23.7M	4.72%153.4M	52.88%111.13M	4.99%67.03M	172.02%23.04M	-14.55%146.49M	-30.76%72.69M	-23.55%63.85M
Cash inflows from operating activities	25.31%2.37B	32.42%1.7B	42.91%902.68M	-17.71%2.52B	-15.77%1.89B	-16.71%1.29B	-7.72%631.64M	-0.17%3.07B	15.18%2.24B	17.70%1.54B
Goods services cash paid	-8.80%281.61M	-3.39%162.6M	-10.15%71.27M	-43.56%318.42M	-35.43%308.78M	-41.90%168.31M	-51.30%79.32M	20.12%564.2M	60.31%478.19M	51.46%289.71M
Staff behalf paid	3.29%451.8M	-1.52%308.86M	-11.92%114.03M	-17.11%570.81M	-10.60%437.41M	-5.53%313.61M	4.94%129.46M	40.39%688.62M	41.88%489.25M	43.67%331.99M
All taxes paid	91.94%357.96M	88.21%228.48M	11.09%88.15M	-43.12%257.94M	-53.34%186.49M	-49.65%121.4M	-47.60%79.35M	5.93%453.49M	25.59%399.71M	21.34%241.1M
Cash paid relating to other operating activities	10.33%403.58M	3.12%253.51M	17.15%122.13M	-3.55%459.58M	4.55%365.81M	5.79%245.84M	-12.20%104.25M	9.81%476.51M	9.67%349.9M	17.16%232.38M
Cash outflows from operating activities	15.13%1.49B	12.28%953.46M	0.82%395.58M	-26.39%1.61B	-24.38%1.3B	-22.46%849.17M	-29.48%392.38M	19.79%2.18B	34.10%1.72B	33.65%1.1B
Net cash flows from operating activities	47.72%871.6M	71.58%749.27M	111.94%507.1M	3.73%916.74M	12.37%590.04M	-2.67%436.7M	86.83%239.26M	-29.26%883.8M	-21.17%525.09M	-8.87%448.67M
Investing cash flow
Cash received from disposal of investments	--1.55B	--1.03B	--422M	----	--0	----	----	-49.84%2.2B	-9.01%2.1B	12.67%1.8B
Cash received from returns on investments	--24.46M	--8.18M	--2.53M	----	--0	----	----	-63.34%10.52M	-41.49%10.48M	-22.32%9.66M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset	-59.33%4.89M	-99.25%69.83K	-99.14%69.03K	82.51%12.6M	6,418.83%12.02M	4,930.87%9.28M	4,384.80%8.02M	599.46%6.91M	-83.80%184.4K	-78.32%184.4K
Cash inflows from investing activities	12,997.70%1.57B	11,091.74%1.04B	5,192.05%424.6M	-99.43%12.6M	-99.43%12.02M	-99.49%9.28M	-99.56%8.02M	-49.78%2.22B	-9.30%2.11B	12.35%1.81B
Cash paid to acquire fixed assets intangible assets and other long-term assets	77.76%179.48M	76.59%128.1M	170.66%95.87M	-48.04%247.25M	-75.84%100.96M	-74.62%72.54M	-75.77%35.42M	-11.45%475.89M	-4.08%417.89M	-0.59%285.87M
Cash paid to acquire investments	--3.57B	--2.03B	--1.17B	-99.27%15M	--0	----	----	-54.98%2.05B	-39.51%1.95B	2.33%1.65B
Cash paid relating to other investing activities	----	----	----	----	----	----	----	--184.02K	----	----
Cash outflows from investing activities	3,616.42%3.75B	2,868.76%2.15B	3,468.27%1.26B	-89.62%262.25M	-95.74%100.96M	-96.25%72.54M	-98.03%35.42M	-50.38%2.53B	-35.29%2.37B	1.89%1.94B
Net cash flows from investing activities	-2,348.52%-2.18B	-1,662.98%-1.12B	-2,963.44%-839.27M	18.39%-249.65M	65.05%-88.94M	48.69%-63.27M	-257.25%-27.4M	54.36%-305.9M	80.85%-254.49M	57.01%-123.29M
Financing cash flow
Cash received from capital contributions	--0	----	----	-99.81%128.11K	--128.11K	--128.11K	--128.11K	-65.51%67.29M	----	----
Cash from borrowing	-60.04%294.43M	-41.27%262.16M	-23.37%251.83M	157.47%762.92M	332.91%736.78M	--446.37M	--328.63M	--296.32M	--170.19M	----
Cash received relating to other financing activities	-60.79%50M	-61.44%50M	----	1,063.62%130.17M	1,262.90%127.51M	1,875.51%129.66M	-87.37%437.77K	25.08%11.19M	3,253.97%9.36M	-32.78%6.56M
Cash inflows from financing activities	-60.15%344.43M	-45.82%312.16M	-23.50%251.83M	138.32%893.21M	381.44%864.41M	8,678.58%576.16M	9,396.94%329.2M	-68.83%374.79M	-84.95%179.55M	-99.45%6.56M
Borrowing repayment	39.21%364.16M	12,637.81%254.76M	--126.5M	--344.5M	--261.59M	--2M	----	----	----	----
Dividend interest payment	-40.02%334.67M	-40.03%330.44M	7.86%5.53M	-22.98%561.79M	-22.51%557.94M	-23.47%550.99M	--5.13M	37.36%729.42M	35.59%720M	35.59%719.99M
Cash payments relating to other financing activities	-2.76%373.29M	44.74%373.29M	--213M	3,783.19%438.84M	7,293.43%383.87M	--257.91M	----	-97.77%11.3M	-98.21%5.19M	----
Cash outflows from financing activities	-10.91%1.07B	18.20%958.49M	6,628.19%345.04M	81.60%1.35B	65.94%1.2B	12.63%810.89M	--5.13M	-28.58%740.72M	-11.73%725.19M	35.59%719.99M
Net cash flows from financing activities	-114.67%-727.69M	-175.35%-646.33M	-128.76%-93.21M	-23.50%-451.91M	37.87%-338.98M	67.10%-234.73M	9,249.00%324.07M	-321.54%-365.93M	-247.04%-545.64M	-208.59%-713.42M
Net cash flow
Exchange rate change effecting cash and cash equivalents	-4,146.55%-787.74K	428.53%95.71K	78.47%-48.88K	131.31%11.39K	-101.49%-18.55K	-104.43%-29.13K	-751.92%-226.98K	-756,607.69%-36.4K	1,771.24%1.24M	6,877.56%657.23K
Net increase in cash and cash equivalents	-1,355.16%-2.03B	-830.02%-1.01B	-179.41%-425.43M	1.54%215.19M	159.20%162.1M	135.80%138.67M	259.56%535.71M	-71.53%211.93M	6.18%-273.8M	-144.91%-387.39M
Add:Begin period cash and cash equivalents	8.52%2.74B	8.52%2.74B	8.52%2.74B	9.16%2.53B	9.16%2.53B	9.16%2.53B	9.16%2.53B	47.41%2.31B	47.41%2.31B	47.41%2.31B
End period cash equivalent	-73.71%706.92M	-35.11%1.73B	-24.36%2.32B	8.52%2.74B	31.75%2.69B	38.30%2.67B	24.30%3.06B	9.16%2.53B	59.64%2.04B	-20.78%1.93B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

300529 Jafron Biomedical

Jafron Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target